Publicaciones (12) Publicaciones de SOLANGE KAPETANOVIC GARCÍA

2023

  1. Follow-up regimens for carriers of hereditary transthyretin variants

    Medicina Clinica

  2. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

    The Lancet Neurology, Vol. 22, Núm. 5, pp. 395-406

2022

  1. Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus)

    Neurologia, Vol. 37, Núm. 3, pp. 216-228

  2. FXR1 -related congenital myopathy: expansion of the clinical and genetic spectrum

    Journal of Medical Genetics, Vol. 59, Núm. 11, pp. 1069-1074

  3. Nusinersen in adult patients with 5q spinal muscular atrophy: A multicenter observational cohorts' study

    European Journal of Neurology, Vol. 29, Núm. 11, pp. 3337-3346

  4. Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy

    European Journal of Neurology, Vol. 29, Núm. 12, pp. 3666-3675

2021

  1. Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 8, Núm. 5

2020

  1. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease

    Neurologia, Vol. 35, Núm. 3, pp. 185-206

2019

  1. Akinetic mutism and status epilepticus due to Epstein Barr virus encephalitis

    Clinical Neurology and Neurosurgery, Vol. 185

  2. Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS

    American Journal of Human Genetics, Vol. 105, Núm. 1, pp. 151-165

  3. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease

    Medicina Clinica, Vol. 153, Núm. 2, pp. 82.e1-82.e17

2018

  1. FSHD type 2 and Bosma arhinia microphthalmia syndrome

    Neurology, Vol. 91, Núm. 6, pp. e562-e570